Guided Therapeutics, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 4/18/2017
Contact Info
  • 5835 Peachtree Corners East
  • Suite D
  • Norcross, GA 30092

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2017 10-Q
CIK 0000924515
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3845 - Electromedical equipment
Incorporated In: DE, USA
Year of Inc. 1992
Employees 10 a/o Nov 16, 2016
Company Officers/Contacts
Gene S. Cartwright CEO, CFO
Mark L. Faupel COO
James Clavijo CFO
Bill Wells Director, Corp. Comm.
Company Directors
Michael C. James Chairman
Richard P. Blumberg
Gene S. Cartwright
John E. Immhoff
Service Providers
Accounting/Auditing Firm
66 South Pearl Street, Suite 401
Albany, 12207
United States
Securities Counsel
Jones Day
1420 Peachtree st.
Atlanta, GA, 30309
United States
Investor Relations Firm

Not Available
Company History
  • Formerly=SpectRx, Inc. until 5-2008
GTHP Security Details
Share Structure
Market Value1 $304,450 a/o Jun 26, 2017
Authorized Shares 1,000,000,000 a/o Apr 13, 2017
Outstanding Shares 1,834,039 a/o May 15, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.001
Transfer Agent(s) Verified by Transfer Agent
Computershare Trust Company, N.A.
Shareholders of Record 150 a/o Apr 13, 2017
Short Selling Data
Short Interest 2,746 (-42.23%)
May 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security